Indeed, the capability of FcRH5 CAR-T cells to efficiently recognize and lyse FcRH5+ mantle lymphoma cell line Mino has been illustrated in present study, and we plan to systemically evaluate the anti-tumor efficacy of FcRH5 CAR-T cells in numerous B-cell malignancies. Here, FCRL5 is linked to neoplasm.